// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Age-related muscle strength decline in mid-late life varies in men and women and is associated with diet and physical activity: observations from the Hertfordshire Cohort Study

Jean Zhang - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Occupational and leisure activities as a risk factor for hip and knee revision surgery

Elena Zaballa Lasala - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluating the WASTEd: a new co-produced patient-reported measure of axial spondyloarthritis (axSpA) fatigue and energy

Nathan A Pearson - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Working collaboratively with patients as research partners in the co-production of the WASTEd: a measure of fatigue and energy in axial spondyloarthritis (axSpA)

Nathan A Pearson - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Axial spondyloarthritis

N/A

Muscle weakness affects function differently in males and females in inclusion body myositis: providing results for focused clinical care and clinical trial design

Jacob Williams - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inclusion body myositis

N/A

Trends in ultrasound guided musculoskeletal injections at one tertiary care centre over 6 years

Kunal Lall - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

N/A

Group counselling: a holistic care model

Kavitha Nadesalingam - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The experiences of and preferences for delivery of outpatient rheumatology services in adults diagnosed with axSpA living in the UK: a qualitative study

Nicky Wilson - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

What is the role of cortisol and short Synacthen testing in patients weaning off long term glucocorticoids?

Ruth Smith - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Glucocorticoid

Introduction of video consultation into the general rheumatology clinic

Sian M Griffith - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The changing face of rheumatology referrals 2011-2018

Mark Ford - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Value of the clinical nurse specialist role in the care of patients with systemic lupus erythematosus: the patient experience

Alison N Culshaw - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

The impact of musculoskeletal ultrasound on the referral of patients with suspected inflammatory arthritis from primary care

Kenneth F Baker - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Multi-centre cross-specialty recommendations for the investigation of suspected adult onset secondary haemophagocytic lymphohistiocytosis (HLH)

Strachan Mackenzie - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hemophagocytic lymphohistiocytosis

N/A

Improving patient care through a collaborative effort in the Leeds Combined Psoriatic Service: an effective provision of multi-specialty input

Claire Vandevelde - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implementation of advanced practice rheumatology clinics

Laura M Gotting - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The effectiveness of group physiotherapy interventions for hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD): a service evaluation project

Dolcie M Paxton - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ehlers Danlos syndrome

N/A

Evaluation of a 10-week progressive resistance training programme for people with inflammatory arthritis

Jade Skeates - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

CCG biologics pathways: re-introduction of the postcode lottery by stealth

Jatin Mistry - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

N/A

Intensive management in moderate established rheumatoid arthritis: the titrate trial

Elena Nikiphorou - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved